Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares at $25.57 ($897K) on 2026-10-14, disclosed to the SEC on 2026-10-16.
Scheduled sale ($897k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.57 | 6,781 | $173K | 19.3% |
| 2 | $25.82 | 5,100 | $132K | 14.7% |
| 3 | $25.61 | 11,881 | $304K | 33.9% |
| 4 | $24.21 | 11,581 | $280K | 31.2% |
| 5 | $25.45 | 300 | $8K | 0.9% |
| Total | $25.18 avg | 35,643 |
| $897K |
| 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |